Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Zhina Majdzadeh Ardekani, Ana L Lorenzo-Leal & Horacio Bach. (2024) Nanomedicine-Mediated Drug Delivery for Potential Treatment of Inflammatory Bowel Disease: A Narrative Review. Nanomedicine 19:2, pages 163-179.
Read now
Read now
Min Chen, Huanrong Lan, Ketao Jin & Yun Chen. (2023) Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives. Drug Delivery 30:1.
Read now
Read now
Fengqian Chen, Qi Liu, Yang Xiong & Li Xu. (2021) Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. International Journal of Nanomedicine 16, pages 4225-4237.
Read now
Read now
Articles from other publishers (19)
Limei Zhang, Peng Ye, Huatai Zhu, Liyu Zhu, Yuting Ren & Jiandu Lei. (2024) Bioinspired and biomimetic strategies for inflammatory bowel disease therapy. Journal of Materials Chemistry B 12:15, pages 3614-3635.
Crossref
Crossref
Sonia Chauhan & Ranjit K. Harwansh. (2024) Recent advances in nanocarrier systems for ulcerative colitis: A new era of targeted therapy and biomarker integration. Journal of Drug Delivery Science and Technology 93, pages 105466.
Crossref
Crossref
Hua Liu, Yanmiao Fan, Jie Zhong, Michael Malkoch, Zhengwei Cai & Zhengting Wang. (2023) Advance in oral delivery of living material. Biomedical Technology 3, pages 26-39.
Crossref
Crossref
Federica Di Vincenzo, Ylenia Yadid, Valentina Petito, Valeria Emoli, Letizia Masi, Daniela Gerovska, Marcos Jesus Araúzo-Bravo, Antonio Gasbarrini, Birgitte Regenberg & Franco Scaldaferri. (2023) Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies. Cells 12:15, pages 1953.
Crossref
Crossref
Ana Paula da Fonseca Machado, Henrique Silvano Arruda, Lívia Mateus Reguengo, Ludmilla David de Moura, Fabíola Vieira de Carvalho, Roberto de Paula do Nascimento & Mario Roberto Marostica Junior. 2023. Natural Plant Products in Inflammatory Bowel Diseases. Natural Plant Products in Inflammatory Bowel Diseases
319
364
.
Omprakash Sunnap, Singaravadivel Subramanian, Praveen Kumar Vemula & Sekar Karuppannan. (2022) Zingerone‐encapsulated Solid Lipid Nanoparticles as Oral Drug‐delivery Systems to Potentially Target Inflammatory Diseases. ChemNanoMat 8:12.
Crossref
Crossref
Runxin Xu, Marie-Christin Weber, Xinkai Hu, Philipp-Alexander Neumann & Nazila Kamaly. (2022) Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy. Seminars in Immunology 61-64, pages 101664.
Crossref
Crossref
Chi-Pin James Wang, Min Ji Byun, Se-Na Kim, Wooram Park, Hee Ho Park, Tae-Hyung Kim, Jung Seung Lee & Chun Gwon Park. (2022) Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment. Journal of Controlled Release 345, pages 1-19.
Crossref
Crossref
Ying Cai, Luoxin Zhang, Youjian Zhang & Rong Lu. (2022) Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer. Pharmaceutics 14:4, pages 822.
Crossref
Crossref
Mei Yang, Chunhua Yang, Yujie Zhang, Xiangji Yan, Yana Ma, Yuanyuan Zhang, Yameng Cao, Qiuran Xu, Kangsheng Tu & Mingzhen Zhang. (2022) An oral pH-activated “nano-bomb” carrier combined with berberine by regulating gene silencing and gut microbiota for site-specific treatment of ulcerative colitis. Biomaterials Science 10:4, pages 1053-1067.
Crossref
Crossref
Amandeep Singh, Uttam Kumar MandalRaj Kumar Narang. (2022)
Development and
In Vivo
Evaluation of Pectin Based Enteric Coated Microparticles Loaded with Mesalamine and
Saccharomyces boulardii
for Management of Ulcerative Colitis
. ASSAY and Drug Development Technologies 20:1, pages 22-34.
Crossref
Crossref
Eden Mariam Jacob, Ankita Borah, Sindhu C. Pillai & D. Sakthi Kumar. (2021) Garcinol Encapsulated Ph-Sensitive Biodegradable Nanoparticles: A Novel Therapeutic Strategy for the Treatment of Inflammatory Bowel Disease. Polymers 13:6, pages 862.
Crossref
Crossref
Mei Yang, Yujie Zhang, Yana Ma, Xiangji Yan, Liuyun Gong, Mingzhen Zhang & Baojun Zhang. (2020) Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospects. Journal of Bio-X Research 3:4, pages 157-173.
Crossref
Crossref
Lauren J. Mohan, Lauren McDonald, Jacqueline S. Daly & Zebunnissa Ramtoola. (2020) Optimising PLGA-PEG Nanoparticle Size and Distribution for Enhanced Drug Targeting to the Inflamed Intestinal Barrier. Pharmaceutics 12:11, pages 1114.
Crossref
Crossref
Helena Rouco, Patricia Diaz-Rodriguez, Diana P. Gaspar, Lídia M. D. Gonçalves, Miguel Cuerva, Carmen Remuñán-López, António J. Almeida & Mariana Landin. (2020) Rifabutin-Loaded Nanostructured Lipid Carriers as a Tool in Oral Anti-Mycobacterial Treatment of Crohn’s Disease. Nanomaterials 10:11, pages 2138.
Crossref
Crossref
Yunyue Zhang, Maya Thanou & Driton Vllasaliu. (2020) Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease. European Journal of Pharmaceutics and Biopharmaceutics 155, pages 128-138.
Crossref
Crossref
Kelly Van Looveren, Charlotte Wallaeys & Claude Libert. (2020) Potential of glucocorticoids to treat intestinal inflammation during sepsis. Current Opinion in Pharmacology 53, pages 1-7.
Crossref
Crossref
Michael Camilleri. (2019) What’s in the pipeline for lower functional gastrointestinal disorders in the next 5 years?. American Journal of Physiology-Gastrointestinal and Liver Physiology 317:5, pages G640-G650.
Crossref
Crossref
Rana Bakhaidar, Joshua Green, Khaled Alfahad, Shazia Samanani, Nabeehah Moollan, Sarah O’Neill & Zebunnissa Ramtoola. (2019) Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets. Pharmaceutics 11:10, pages 514.
Crossref
Crossref